Table 2

Lipid levels during treatment with rituximab in RA patients (n=49)

Baseline1 Month3 Months6 Months
Total cholesterol, mmol/l5.26+0.14+0.08+0.03
HDL cholesterol, mmol/l1.35+0.10*+0.03+0.07
Atherogenic index4.32−0.40**−0.30−0.40**
LDL cholesterol, mmol/l3.26−0.01+0.02−0.08
Triglycerides, mmol/l1.56−0.00−0.02+0.02
Apo A-I, g/l1.67+ 0.07*+ 0.03+0.03
Apo B, g/l0.90+0.01+0.00−0.00
Apo B to Apo A-I ratio0.56−0.03*−0.02−0.03
  • Values of lipids at different time points are regression coefficients (βs).

  • β Represents the estimated change at a different time point in GEE analysis.

  • * p<0.05,

  • ** p<0.10.

  • GEE, generalised estimating equation; HDL, high density lipoprotein; LDL, low density lipoprotein; RA, rheumatoid arthritis.